Freshpet Should Stop “Human Grade” Claims, US Ad Body Says

Why It Matters

The ruling underscores growing regulatory scrutiny of pet‑food marketing claims, which could reshape brand positioning and consumer trust across the industry.

Key Takeaways

• NAD recommends Freshpet drop “human grade” claims
• Three ads examined; two deemed misleading
• Freshpet already altered one commercial voluntarily
• Company posted $1 bn sales, forecasts 7‑10% growth
• Pet‑food market faces tighter advertising oversight

Pulse Analysis

The National Advertising Division, a self‑regulatory arm of BBB National Programs, stepped in to evaluate Freshpet’s promotional content after The Farmer’s Dog alleged that the wording suggested a "human grade" status. While the NAD affirmed the factual basis of Freshpet’s nutritional claims, it flagged two video ads for implying parity with human food, a distinction the agency says could mislead consumers. By applying its Fast‑Track SWIFT process, NAD expedited the review, ultimately urging Freshpet to eliminate the contested language and reinforcing the importance of clear, substantiated messaging in pet‑food advertising.

For Freshpet, the directive arrives at a pivotal moment. The brand has built its market identity around fresh, refrigerated dog food positioned as a healthier alternative to traditional kibble. The "human grade" narrative, though appealing, blurs the line between pet and human nutrition standards, potentially inviting regulatory pushback and consumer skepticism. Competitor The Farmer’s Dog, which markets its own fresh meals, leveraged the dispute to highlight its compliance posture, intensifying competitive pressure. Freshpet’s swift removal of the disputed line demonstrates a proactive approach to preserving brand credibility while navigating an increasingly litigious advertising landscape.

Financially, Freshpet’s recent disclosure of surpassing $1 bn in annual revenue signals robust demand for premium pet nutrition, yet the company tempered expectations with a modest 7‑10% growth outlook for 2026 and adjusted EBITDA projected between $205 m and $215 m. The advertising ruling may modestly impact short‑term marketing spend, but the broader trend toward premiumization suggests sustained market expansion. As regulators and industry groups tighten oversight, pet‑food manufacturers will likely prioritize transparent labeling and evidence‑based claims to maintain consumer confidence and avoid costly compliance setbacks.